Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling

Molecular profiling from liquid biopsy, in particular cell-free DNA (cfDNA), represents an attractive alternative to tissue biopsies for the detection of actionable targets and tumor monitoring. In addition to PCR-based assays, Next Generation Sequencing (NGS)-based cfDNA assays are now commercially...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Sabrina, Spiegl, Benjamin, Perakis, Samantha O., Ulz, Christine M., Abuja, Peter M., Kashofer, Karl, van der Leest, Paul, Azpurua, Maria Aguirre, Tamminga, Menno, Brudzewsky, Dan, Rothwell, Dominic G., Mohan, Sumitra, Sartori, Alexander, Lampignano, Rita, Konigshofer, Yves, Sprenger-Haussels, Markus, Wikman, Harriet, Bergheim, Inger R., Kloten, Vera, Schuuring, Ed, Speicher, Michael R., Heitzer, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352370/
https://www.ncbi.nlm.nih.gov/pubmed/32560092
http://dx.doi.org/10.3390/cancers12061588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352370/
https://www.ncbi.nlm.nih.gov/pubmed/32560092
http://dx.doi.org/10.3390/cancers12061588

Ejemplares similares